Premier Research
 
   
 
Skip Navigation Links.

Premier Research provides a reliable, fully validated, 21 CFR Part 11 compliant Interactive Voice Response System (IVRS) that allows our sponsors to automate many aspects of their trial with added flexibility and confidence. Regardless of complexity, scale and duration of a study, Premier Research’s IVRS can be utilized to increase efficiency in your clinical trial.
 
Premier Research has employed our IVRS system in more than 80 Phase 2 and 3 trials conducted throughout North America, Europe, South Africa and Australia. Our IVRS group includes a strong, stable team of developers and support personnel that have extensive experience with Schedule II and Schedule III substances. 

Benefits of our IVRS


  • Randomization into complex protocols made simple for the investigator
  • Oversight of patient enrollment by project team to prevent over-enrollment
  • System provides Study Coordinators with improved drug accountability and expiry information
  • Less drug wastage with inventory management provides cost control
  • Improved data accuracy and availability of patient diary data
  • Use of robust, scalable technology allows for timely development of protocols
  • Flexible systems allow for adaptive design
  • 24/7 multilingual capability and support
  • Full Business Continuity Plans and Disaster Recovery Plans in place ensuring maximum system availability

Services

  • Patient Randomization including Centralized, Stratified and Adaptive Algorithms
  • Titration/Dose Escalation
  • Clinical Supplies Management including Predictive Algorithms
  • Subject Diary Capture including Compliance Monitoring
  • Visit Tracking
  • Data Exports
  • Customized Reporting Available Via Secure Internet Connection 
Case Studies
Case Study  Real-Time Access to Study Data
 See All Case Studies
Upcoming Events
Event  30-Aug-08 ESC Congress 2008
Event  04-Sep-08 PAINWeek 2008
Event  10-Sep-08 ICR's East of England Forum
 See All Events
 
Privacy Policy | Site Map | Locations
© 2008 Premier Research Group